Latest News
-
Changes in the B. Braun SE Executive Board: Dr. Meinrad Lugan moves to the Executive Board of the family holding company
Read MoreEffective April 1, 2022, Dr. Meinrad Lugan will change from the B. Braun SE Executive Board to the Executive Board of affiliated company B. Braun Familienholding Verwaltungs SE at his own request as part of a planned generational change. Dr. Lugan is thus giving up his responsibilities for the Hospital Care division.
-
B. Braun acquires Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates
Read MoreWith the full integration of Intermedt Medizin & Technik GmbH into the Group, B. Braun has completed the extensive product portfolio of its B. Braun Avitum division as a systems provider for extracorporeal blood treatment (dialysis).
-
B. Braun expands footprint in Vietnam with ground-breaking of new factory
Read MoreB. Braun celebrated the official ground-breaking of a state-of-the-art Haemodialysis Concentrate Factory in the Thanh Oai Industrial Complex in Hanoi, Vietnam on January 10, 2022.
-
Dr Jens von Lackum appointed to the Management Board of B. Braun SE
Read MoreMelsungen. At its meeting on December 7th 2021, the Supervisory Board of B. Braun SE appointed Dr Jens von Lackum as deputy member of the Management Board of B. Braun SE.
-
Shaping the future of vascular stenting – REVA Medical and B. Braun form new partnership
Read MoreB. Braun and REVA Medical hereby announce the strategic partnership for the distribution of Fantom® Encore - a bioresorbable scaffold for coronary interventions, manufactured with REVA's patented material Tyrocore. B. Braun will start active distribution of the products in Germany and Switzerland in November 2021, with additional countries to follow soon.
-
Aesculap wins iF DESIGN AWARD with AESCULAP Aicon®
Read MoreAesculap received together with its partner, the design agency Design3, an iF DESIGN AWARD 2021.
-
B. Braun business performance robust in 2020: firm foundation laid for continued growth in the next decade
Read MoreThe B. Braun Group recorded € 7,426.3 million in sales in Fiscal Year 2020 (previous year: € 7,471.3 million).
-
Changes in B. Braun SE Supervisory Board
Read MoreThe Supervisory Board of the international medical technology and pharmaceutical company B. Braun has been reconstituted.
-
Product Success: One million SeQuent® Please sold
Read MoreIn December 2020, B. Braun Vascular Systems produced and sold its one millionth drug coated balloon catheter.
-
Vaccination Supplies: Warning against Fraud Attempts with Supposed B. Braun Products
Read MoreOnce again, individuals are attempting to abuse the coronavirus situation and distribute products necessary for coronavirus vaccination, such as syringes or needles, using counterfeit B. Braun business documents.
-
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
Read MoreJoint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients.
-
B. Braun Receives FDA Clearance for SpaceStation MRI
Read MoreAllows Space® Infusion Pumps to Continuously Deliver Medications Within the MRI Suite
-
After More Than 30 Years of Service, Management Board Member Caroll H. Neubauer Retires from B. Braun
Read MoreDr. Jean-Claude Dubacher Appointed Chairman and Chief Executive Officer of B. Braun of America Inc.
-
B. Braun for Children Campus is online
Read MoreThe digital learning platform offers age-appropriate educational videos, interactive games and exciting tasks and exercises for children.
-
Story continues: Scam Alert for Sale of B. Braun products
Read MoreAs already known and often reported, fraudsters use the current corona crisis for their purposes.
-
2019 fiscal year: B. Braun increases sales — investments at a high level
Read MoreAll divisions contributed to this growth in sales.
-
B. Braun about online shops selling B. Braun disinfectants and protective equipment
Read MoreB. Braun observes that, in connection with the coronavirus pandemic, some sellers on take advantage of the increased demand for disinfectants and protective equipment in online marketplaces and offer these products at prices several times higher than the average normal selling price.
-
Scam Alert for Sale of B. Braun Masks
Read MoreB. Braun has been made aware that certain individuals are trying to abuse the supply shortage connected to the coronavirus situation and are using our company name to sell fraudulent products and to send fake invoices.
-
Addition to the Management Board of B. Braun: Dr. Stefan Ruppert to Head Human Resources and Legal Divisions
Read MoreThe Supervisory Boards of B. Braun SE and B. Braun Melsungen AG appointed Dr. Stefan Ruppert as Deputy Member of the Management Board responsible for the Human Resources and Legal Divisions as well as to Director of Labor Relations (“Arbeitsdirektor”), effective as of April 1, 2020.
